BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5753 related articles for article (PubMed ID: 3570556)

  • 1. W-7, a calmodulin inhibitor, potentiates dacarbazine cytotoxicity in human neoplastic cells.
    Lönn U; Lönn S
    Int J Cancer; 1987 May; 39(5):638-42. PubMed ID: 3570556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of poly(ADP-ribose) synthetase potentiates cell dacarbazine cytotoxicity.
    Lönn U; Lönn S
    Biochem Biophys Res Commun; 1987 Feb; 142(3):1089-94. PubMed ID: 3103613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of bleomycin lethality by anticalmodulin drugs: a role for calmodulin in DNA repair.
    Chafouleas JG; Bolton WE; Means AR
    Science; 1984 Jun; 224(4655):1346-8. PubMed ID: 6203171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of dacarbazine damage of human neoplastic cell DNA by aphidicolin.
    Lönn U; Lohn S
    Cancer Res; 1987 Jan; 47(1):26-30. PubMed ID: 3098406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity, calmodulin and DNA lesions in cells treated with streptozotocin.
    Lönn U; Lönn S
    Biochem Pharmacol; 1988 Sep; 37(18):3441-6. PubMed ID: 2971359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of DNA damage and cytotoxicity by calmodulin antagonists.
    Rosenthal SA; Hait WN
    Yale J Biol Med; 1988; 61(1):39-49. PubMed ID: 2452522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced DNA damage induced in human melanoma cells by dacarbazine in the presence of deoxyribonucleosides.
    Lönn U; Lönn S; Nylen U; Winblad G
    Cancer Res; 1989 Jun; 49(11):2921-4. PubMed ID: 2785848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of mouse preimplantation development: inhibitory effect of the calmodulin antagonist W-7 on the first cleavage.
    Poueymirou WT; Schultz RM
    Mol Reprod Dev; 1990 Jul; 26(3):211-6. PubMed ID: 2115792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.
    Hidaka H; Sasaki Y; Tanaka T; Endo T; Ohno S; Fujii Y; Nagata T
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4354-7. PubMed ID: 6945588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calmodulin antagonist W 13 prevents DNA repair after bleomycin treatment of human urological tumor cells growing on extracellular matrix.
    Pavelić K
    Int J Biochem; 1987; 19(11):1091-5. PubMed ID: 2448175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity studies of human melanoma cells and fibroblasts.
    Parsons PG; Brown SG
    Aust J Exp Biol Med Sci; 1979 Apr; 57(2):161-70. PubMed ID: 485982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships among cell survival, O6-alkylguanine-DNA alkyltransferase activity, and reactivation of methylated adenovirus 5 and herpes simplex virus type 1 in human melanoma cell lines.
    Maynard K; Parsons PG; Cerny T; Margison GP
    Cancer Res; 1989 Sep; 49(17):4813-7. PubMed ID: 2547518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists.
    Lazo JS; Hait WN; Kennedy KA; Braun ID; Meandzija B
    Mol Pharmacol; 1985 Mar; 27(3):387-93. PubMed ID: 2579318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A calmodulin antagonist has no effect on the repair of X-ray-induced damage in a murine mammary carcinoma cell line.
    Ridinger DN; Loh SN; Warters RL; Dethlefsen LA
    Radiat Res; 1986 Nov; 108(2):127-38. PubMed ID: 3786673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased growth inhibition and DNA lesions in human colon adenocarcinoma cells treated with methotrexate or 5-fluorodeoxyuridine followed by calmodulin inhibitors.
    Lönn U; Lönn S
    Cancer Res; 1988 Jun; 48(12):3319-23. PubMed ID: 2453268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitro.
    Kikuchi Y; Iwano I; Kato K
    Biochem Biophys Res Commun; 1984 Aug; 123(1):385-92. PubMed ID: 6541042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: II. DNA damage, repair and chromatin changes.
    Smith PJ; Mircheva J; Bleehen NM
    Br J Cancer; 1986 Jan; 53(1):105-14. PubMed ID: 2418859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calmodulin antagonists and cAMP inhibit ionizing-radiation-enhancement of double-strand-break repair in human cells.
    Wang Y; Mallya SM; Sikpi MO
    Mutat Res; 2000 Jun; 460(1):29-39. PubMed ID: 10856832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trifluoperazine inhibits phagocytosis in a macrophagelike cultured cell line.
    Horwitz SB; Chia GH; Harracksingh C; Orlow S; Pifko-Hirst S; Schneck J; Sorbara L; Speaker M; Wilk EW; Rosen OM
    J Cell Biol; 1981 Dec; 91(3 Pt 1):798-802. PubMed ID: 6120173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulatory effect of interleukin-1 alpha on proliferation through a Ca2+/calmodulin-dependent pathway of a human thyroid carcinoma cell line, NIM 1.
    Inokuchi N; Zeki K; Morimoto I; Nakano Y; Fujihira T; Yamashita U; Yanagihara N; Izumi F; Eto S
    Jpn J Cancer Res; 1995 Jul; 86(7):670-6. PubMed ID: 7559085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 288.